Endovascular
Devices and Complications Learning Series
Drug Coated Balloons and Local Drug Delivery
Episodes
Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon With Conventional Balloon Angioplasty for In-Stent Restenosis
20 min.
Drug-Coated Balloons BTK: What’s the Latest in the Field?
17 min.
Vascular Drug Delivery: Distilling the Paclitaxel Controversy
10 min.
Real World Evidence About Paclitaxel Safety
9 min.
Patient-Level Meta-analysis on Paclitaxel Safety
9 min.
FDA Opinion About Lessons Learned From the Paclitaxel Controversy
16 min.
Deep Venous Disease and Optimal DVT Intervention: State-of-the-Art Stenting, Valves, Imaging, and Future Directions
22 min.
Role of Drug-Eluting Technologies as Definitive Therapy
8 min.
Reflow Medical’s Temporary Spur DES System
3 min.
Hybrid Nano-Coating DES for BTK Disease
6 min.
Sustained Limus Release vs Paclitaxel DCB Treatment in Symptomatic Peripheral Artery Disease: The Limus FLOW Investigator-Initiated, Randomized Controlled Trial
7 min.
Have We Gotten to the Final Word on Paclitaxel Safety?
9 min.